Micro Labs Limited Dapagliflozin Export Data — India (DGFT 2022–2026)

Name: Micro Labs Limited Dapagliflozin Export Records India — #2 Exporter, 442 Shipments, $7.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Dapagliflozin

India Pharmaceutical Trade Intelligence

$49.5M254 Suppliers113 CountriesHS 30049099

ExportsIndia → CANADA25.9%India → IRAQ17.2%

ImportsGERMANY → India$59.4K BRAZIL → India$38.8K

#1 Supplier: AJANTA PHARMA

Micro Labs Limited — Dapagliflozin Exporter #2 | $7.7M Trade Value | TransData Nexus | TransData Nexus

Micro Labs Limited — Dapagliflozin Exporter Profile

Indian Pharmaceutical Exporter · #2 for Dapagliflozin · $7.7M export value · DGFT Verified

Micro Labs Limited is the #2 Indian exporter of Dapagliflozin with $7.7M in export value and 442 verified shipments. Micro Labs Limited holds a 15.5% market share in Dapagliflozin exports across 24 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.

Micro Labs Limited — Dapagliflozin Export Profile: Buyers & Destinations

Micro Labs Limited Dapagliflozin export treemap — buyers and destination countries | TransData Nexus

Where Does Micro Labs Limited Export Dapagliflozin?

Country	Value	Shipments	Share
NIGERIA	$908.9K	19	12.8%
MADAGASCAR	$799.6K	81	11.2%
UGANDA	$792.9K	47	11.1%
ZIMBABWE	$579.7K	15	8.1%
MAURITIUS

Who Are the Top Buyers of Dapagliflozin from Micro Labs Limited?

Buyer	Country	Value	Orders
MICRO NOVA PHARMACEUTICALS IND	NIGERIA	$908.9K	19
SUED & FARGESA	DOMINICAN REPULIC	$592.5K	19
BROWN AND BURK PHILIPPINES INC	PHILIPPINES	$361.3K	11
AL-KAWKAB SCIENTIFIC BUREAU	JORDAN	$351.5K	8
PHILLIPS PHARMACEUTICALS (UGANDA)	UGANDA	$341.7K	12
FTM (MAURITIUS) LIMITED	MAURITIUS	$276.1K	29
LABOREX TANZANIA LTD	TANZANIA	$263.6K	17
E.P.DIS	FRANCE	$253.3K	12
PHILLIPS PHARMACEUTICALS(UGANDA)	UGANDA	$238.5K	15
SOMAPHAR	MADAGASCAR	$234.3K	21

Micro Labs Limited supplies Dapagliflozin to 59 buyers globally. The largest buyer is MICRO NOVA PHARMACEUTICALS IND (NIGERIA), followed by SUED & FARGESA (DOMINICAN REPULIC) and BROWN AND BURK PHILIPPINES INC (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Dapagliflozin Formulations Does Micro Labs Limited Export?

Product Description / Formulation	Value	Shipments
DAPZIN 10 DAPAGLIFLOZIN 10MG TABLETS 3X 10'S	$150.0K	3
DAPZIN 10 ( (DAPAGLIFLOZIN TABLETS 10MG)) ( 3X10S ) ( QTY- 39545.000 )PCS	$135.1K	3
DAPZIN 10DAPAGLIFLOZIN TABLETS 10MG 3X10S QTY- 9135.000 19DRAWBACK	$100.0K	2
DAPAGLIP 10 ( (Dapagliflozin Tablets 10mg) ) ( 3X10S ) ( QTY- 11717.000 )	$100.0K	2
DAPZIN 10 Dapagliflozin Tablets 10mg 3X10S	$92.6K	4
DAPZIN 10 (DAPAGLIFLOZIN TABLETS 10MG) (	$91.0K	8
DAPZIN 5 M (DAPAGLIFLOZIN 5MG & EXTENDEDRELEASE METFORMIN HYDROCHLORIDE 500MG TABLETS)(3X10`S)(QTY- 3900.000)TAX INV N	$76.7K	2
DAPZIN 10 (Dapagliflozin Tablets 10mg) (	$71.1K	11
DAPZIN 5 (Dapagliflozin Tablets 5mg) ( 3	$61.2K	8
DAPZIN 10 ( (DAPAGLIFLOZIN TABLETS 10MG)) ( 3X10S )	$52.7K	4

Micro Labs Limited exports 387 distinct Dapagliflozin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DAPZIN 10 DAPAGLIFLOZIN 10MG TABLETS 3X 10'S with 3 shipments worth $150.0K.

How Does Micro Labs Limited Compare to Nearest Dapagliflozin Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	MICRO LABS LIMITED ★	$7.7M	442	24	$17.3K
1	AJANTA PHARMA LIMITED	$5.2M	103	4	$50.0K
3	ALEMBIC PHARMACEUTICALS LIMITED	$4.8M	95	3	$50.0K

Micro Labs Limited ranks #2 among 254 Indian Dapagliflozin exporters. Average shipment value of $17.3K compared to the market average of $135.5K. The closest competitors by value are AJANTA PHARMA LIMITED and ALEMBIC PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Dapagliflozin Exports?

Port	Shipments	% Share
SAHAR AIR	1,003	19.7%
SAHAR AIR CARGO ACC (INBOM4)	791	15.5%
DELHI AIR CARGO ACC (INDEL4)	761	14.9%
DELHI AIR	612	12.0%
Bombay Air	194	3.8%
BANGALORE ACC (INBLR4)	189	3.7%
BANGALORE AIR	160	3.1%
NHAVA SHEVA SEA (INNSA1)	136	2.7%

Geopolitical & Trade Policy Impact on Micro Labs Limited's Dapagliflozin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.

Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.

The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)

Micro Labs Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)

However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Dapagliflozin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 465 individual customs records matching Micro Labs Limited exporting Dapagliflozin, covering 387 formulations to 27 countries via 59 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 113+ countries, 502+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Dapagliflozin

Dapagliflozin

Micro Labs Limited — Dapagliflozin Exporter Profile

Micro Labs Limited — Dapagliflozin Export Profile: Buyers & Destinations

Where Does Micro Labs Limited Export Dapagliflozin?

Who Are the Top Buyers of Dapagliflozin from Micro Labs Limited?

What Is India's Total Dapagliflozin Export Value and How Much Does Micro Labs Limited Contribute?

What Is the Average Shipment Value for Micro Labs Limited's Dapagliflozin Exports?

How Does Micro Labs Limited Compare to Other Indian Dapagliflozin Exporters?

What Dapagliflozin Formulations Does Micro Labs Limited Export?

Regulatory Requirements: Exporting Dapagliflozin to Key Markets

Nigeria — NAFDAC

How Does Micro Labs Limited Compare to Nearest Dapagliflozin Exporters?

Which Indian Ports Ship Dapagliflozin Exports?

What Other Advanced Diabetes Medications Products Does Micro Labs Limited Export?

Geopolitical & Trade Policy Impact on Micro Labs Limited's Dapagliflozin Exports

Micro Labs Limited — Regulatory Compliance & Quality Standards

About Micro Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Dapagliflozin Export Data from Micro Labs Limited

Dapagliflozin Stats

Company Overview

Top Products by Micro Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source